| Literature DB >> 25452819 |
Abstract
INTRODUCTION: Thoracic outlet syndrome (TOS) refers to a group of conditions resulting from compression of the neurovascular structures of the thoracic outlet. The parameters for physical therapy include myofascial release (MFR), neuromuscular therapy (NMT), muscle strengthening, and stretching. This case study examined the effects of neuromuscular therapy, massage, and other manual therapies on a 56-year-old female presenting with bilateral numbness over the forearms and hands on waking. Numbness occurred most days, progressing to "dead rubbery" forearms and hands once or twice a month.Entities:
Keywords: MYMOP2; brachial plexus; entrapment neuropathy; lymphatic massage; neuromuscular therapy; subclavian compression
Year: 2014 PMID: 25452819 PMCID: PMC4240700 DOI: 10.3822/ijtmb.v7i4.221
Source DB: PubMed Journal: Int J Ther Massage Bodywork
Figure 1Thoracic outlet anatomy(.
Figure 2Postural analysis (PA), utilizing a grid and plum line.
Description of Massage Techniques Used in Each Session
| 1,2 | MFR (diaphragm)( | 5 min | thoracic inlet |
| MFR( | 20 min | pectoralis major/minor, SCM, scalenii | |
| Lymphatic massage( | 5 min | anterior neck | |
| NMT( | 5 min | upper trapezius, lower trapezius | |
| Broad slow effleurage( | 15 min | upper and midback focusing on erector spinae | |
| 3, 4 | MFR (diaphragm)( | 5 min | thoracic inlet |
| MFR( | 20 min | pectoralis major/minor, SCM, scalenii | |
| NMT( | 20 min | SCM, scalenii, upper and lower trapezius, posterior suboccipitals, levator scapulae | |
| Muscle energy technique( | 3 min | sternoclavicular joint, acromioclavicular joint | |
| Cranial base release( | 2 min | posterior suboccipitals | |
| 5,6 | MFR( | 20 min | anterior chest and rib cage, anterior neck |
| NMT( | 25 min | SCM, scalenii, upper trapezius, levator scapulae, splenius capitis, anterior deltoid, forearm flexors | |
| Muscle energy technique( | 3 min | sternoclavicular joint, acromioclavicular joint | |
| Cranial base release( | 2 min | posterior suboccipitals |
Cervical Spine Active Range of Movement (AROM)
| Flexion | 14.0 cm | 48° | 12.0 cm | 44° |
| Flexion | 10.0 cm | 39° | 8.0 cm | 33° |
| Extension | 16.5 cm | 53° | 17.0 cm | 54° |
| Extension | 17.0 cm | 54° | 17.5 cm | 54° |
| Lateral flexion | 21.5 cm | 11° | 20.0 cm | 17° |
| Lateral flexion | 19.5 cm | 19° | 17.0 cm | 28° |
| Rotation | 15.0 cm | 50° | 14.0 cm | 48° |
| Rotation | 14.0 cm | 48° | 13.5 cm | 47° |
Points of measurement using tape measure:
Flexion and aExtension were measured from suprasternal notch to tip of nose
Atlanto-occipital joint
Seventh cervical vertebrae
Lateral flexion and dRotation were measured from acromion to tip of nose
To facilitate trigonometric calculation for flexion, extension and lateral rotation, a vertical plan view measurement was taken using a horizontal line dissecting both external auditory meatus’s and drawing a perpendicular line to the tip of nose (12.5 cm). For lateral flexion, a vertical plan view measurement was taken using a horizontal line dissecting both external auditory meatus’s and finding the midpoint. From this point, a measurement was made to the acromion (21 cm). Readers will note that improved flexion, lateral flexion, and rotation were indicated with smaller measured values measured at post-treatment, compared to pretreatment. Conversely, in extension, a larger measured value represents an increase in ROM.
Shoulder AROM (reduced range only)
| Medial rotation (right) | 16.0 cm | 44° | 13.5 cm | 36º |
| Medial rotation (left) | 14.5 cm | 39º | 13.0 cm | 34º |
| Lateral rotation (right) | 10.5 cm | 27º | 7.5 cm | 19º |
| Lateral rotation (left) | 12.5 cm | 32º | 8.0 cm | 20º |
All centimeter measurements, taken from tape measure, are from styloid process of ulna to massage table. To facilitate trigonometric calculation, forearm length from styloid process of ulna to olecranon was 23 cm. Readers will note that improved medial and lateral rotation was indicated with smaller measured values measured at post-treatment, compared to pretreatment.
Figure 3Post-treatment PA.
Figure 4MYMOP2 results.